Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19
No proven remedy is identified for COVID-19 yet. SARS-CoV-2, the viral agent, is recognized by some endosomal and cytosolic receptors following cell entry, entailing innate and adaptive immunity stimulation, notably through interferon induction. Impairment in immunity activation in some patients, mo...
Saved in:
Main Authors: | Pouria Mosaddeghi (Author), Farbod Shahabinezhad (Author), Mohammadreza Dorvash (Author), Mojtaba Goodarzi (Author), Manica Negahdaripour (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A
by: M. H. Lahoud, et al.
Published: (2022) -
The dual sides of interferon induction in COVID-19 treatment
by: Sadra Nadimi Parashkouhi, et al.
Published: (2021) -
Witnessing a revolution in the vaccinology field: A thought on its probable impact on future vaccines
by: Manica Negahdaripour, et al.
Published: (2022) -
OralOpioids: Harnessing R Programming and Data Science to Combat Opioid Misuse
by: Ankona Banerjee, et al.
Published: (2023) -
Harnessing Bacteriophages to Combat Antibiotic-Resistant Infections in Africa: A Comprehensive Review
by: Kafayath Fabiyi, et al.
Published: (2024)